You are on page 1of 5

Equity Research INDIA

September 20, 2020


BSE Sensex: 38846 Consumer Staples & Discretionary
ICICI Securities Limited
is the author and Worm’s world view #19: Conversations with HUL
distributor of this report
distributors
Overall revenues have recovered to pre-Covid level due to increased demand of
Sector update health, hygiene and foods products but personal care has still not fully recovered
yet and full range of personal care products are not available to distributors -
that's the insight from our conversations with distributors in Maharashtra and
West Bengal. They further told us, (1) rebranding of Fair & Lovely to Glow &
Lovely has not impacted sales much, (2) there is an increase in distributor’s bad
debts due to permanent closure of few retail stores, (3) price hike of c.8% in tea
products and (4) Nutrition business products have some supply constraints.
 Recovery in revenues: Distributors told us that the overall business is almost same
as pre-Covid as there is an increased demand for health & hygiene and foods
products. Brand wise, sales of Lifebuoy has increased. Further, they told us that the
whole range of products is yet not available especially in personal care. However,
even the demand for personal care products has not fully recovered. Also, they
mentioned that cosmetics business is still struggling and has not recovered.
 New businesses: Distributor told us that health food drinks product range (nutrition
business) is yet not available to them. However, distributors have started keeping
inventory of VWash which HUL recently acquired from Glenmark.
 Rebranding of Fair & Lovely to Glow & Lovely has not impacted the sales
much.
 Increase in distributor’s bad debts: Permanent closure of few retail stores (most
cases these stores were on rent) have led to increase in distributor’s bad debts.
Distributors are finding it difficult to absorb this loss with margins of ~4%.
 Inventory levels: Distributor level inventory has not changed significantly post
lockdown.
 Credit period: HUL has not extended any (extra) credit days for the distributors.
 Price hikes: HUL has taken a price hike of ~8% in Red Label Dust tea and is now at
par in pricing with Tata Tea Agni. There has been reduction in trade
schemes/discounts.
 SKUs (stock keeping units): HUL had reduced the total number of SKUs during
the lockdown to increase productivity in manufacturing units. However, full range of
SKUs is now available to distributors.
We like HUL’s supply chain agility and product portfolio (80% of revenues are
from Health, Hygiene and Nutrition product portfolio). That said, downtrading,
Research Analysts:
although primarily to lower sized packs and not to lower priced brands (yet), and
Manoj Menon potential second order macro impact limits stock upsides. For us, HUL is an
manoj.menon@icicisecurities.com
+91 22 6637 7209 outperformer within consumer staples.
Vismaya Agarwal
vismaya.agarwal@icicisecurities.com We do channel checks. We do network checks. However, >20 years of experience has
+91 22 2277 7632 taught this analyst that on-the-ground checks have utility, if and only if, we don't
Karan Bhuwania extrapolate it as a national trend (as diversity is high in India). Worm's world view is our
karan.bhuwania@icicisecurities.com
+91 22 6637 7351 periodic product on network checks.

Please refer to important disclosures at the end of this report


Consumer Staples & Discretionary, September 20, 2020 ICICI Securities
Figure 1: Valuation summary
CMP TP Upside PE (x) EV/EBITDA (x) ADTV Market Cap
Company (Rs) (Rs) (%) Rating FY21E FY22E FY21E FY22E (US$ mn) (Rs bn) (US$ bn)
Staples
Bajaj Consumer 190 200 5 ADD 13 13 11 11 3.3 27 0.4
Britannia 3,798 3,300 (13) REDUCE 46 44 36 35 39.6 896 12.0
Colgate 1,373 1,500 9 HOLD 42 38 27 25 15.0 385 5.2
Dabur 508 550 8 ADD 53 48 48 43 23.1 891 11.9
Emami 370 400 8 ADD 31 26 23 21 5.2 177 2.4
GCPL 714 750 5 ADD 43 39 31 29 13.3 706 9.4
HUL 2,099 2,500 19 ADD 56 48 41 36 76.1 4,990 66.7
ITC 179 220 23 ADD 15 14 11 10 80.8 2,258 30.2
Jyothy Labs 154 160 4 ADD 25 23 18 17 1.7 55 0.7
Marico 363 420 16 ADD 41 36 29 25 13.6 479 6.4
Nestle 16,087 16,500 3 HOLD 73 59 48 40 32.1 1,555 20.8
Tata Consumer 541 600 11 ADD 64 53 34 31 30.3 504 6.7
Varun Beverages 705 750 6 HOLD 73 37 19 15 2.9 215 2.9

Discretionary
Avenue Supermarts 2,149 1,850 (14) REDUCE 116 61 71 41 22.2 1,406 18.8
Bata 1,335 1,100 (18) REDUCE 163 46 35 20 19.4 172 2.3
Jubilant Foodworks 2,361 2,400 2 ADD 109 56 36 25 28.6 310 4.1
Page Industries 18,664 22,000 18 ADD 150 46 77 30 12.8 214 2.9
Sheela Foam 1,526 1,500 (2) ADD 75 28 38 18 0.8 74 1.0
Titan 1,164 1,100 (5) HOLD 127 52 69 33 51.3 1,055 14.1
United Spirits 544 650 20 ADD 78 37 40 24 23.4 398 5.3
Westlife Development 392 340 (13) HOLD (129) 66 88 20 1.7 64 0.9

Paints
Akzo Nobel 2,164 2,500 16 BUY 47 37 31 24 0.5 95 1.3
Asian Paints 2,028 2,200 8 ADD 73 57 46 37 62.1 1,951 26.1
Berger Paints 579 540 (7) HOLD 98 79 59 50 12.2 562 7.5
Kansai Nerolac 510 460 (10) HOLD 59 45 36 28 1.9 279 3.7
Source: Company data, I-Sec research

EV/ sales (x) P/B (x) P/CEPS (x) RoE (%) RoCE (%) CAGR (FY20-22E) (%)
Company FY21E FY22E FY21E FY22E FY21E FY22E FY21E FY22E FY21E FY22E Revenues EBITDA PAT
Staples
Bajaj Consumer 3.1 2.9 3 3 13 13 27 23 29 24 4 6 7
Britannia 6.7 6.5 16 13 42 40 36 30 25 21 11 18 20
Colgate 7.9 7.3 20 19 34 31 54 57 64 67 6 11 12
Dabur 10.2 9.3 12 11 46 43 24 23 18 17 6 12 10
Emami 6.4 5.9 9 8 32 25 29 33 32 34 5 9 11
GCPL 7.3 6.7 9 8 38 35 21 21 17 17 7 10 9
HUL 11.0 9.7 11 11 50 43 34 23 28 19 15 19 22
ITC 4.3 3.8 4 4 13 12 24 26 25 29 8 7 4
Jyothy Labs 3.1 2.9 4 4 20 18 18 19 16 16 9 16 20
Marico 6.1 5.6 14 13 36 32 36 37 32 33 7 11 11
Nestle 11.5 9.9 62 47 62 52 95 90 39 40 11 16 15
Tata Consumer 4.6 4.2 2 2 48 41 5 5 6 6 10 11 17
Varun Beverages 3.7 3.0 5 5 24 18 8 14 9 14 5 2 1

Discretionary
Avenue Supermarts 5.3 3.8 11 10 88 52 10 17 14 22 23 27 30
Bata 8.2 5.2 9 8 43 24 5 18 9 24 2 1 7
Jubilant Foodworks 8.2 6.3 24 18 48 33 23 36 17 27 11 19 36
Page Industries 8.6 5.9 24 19 101 39 16 46 14 36 9 14 15
Sheela Foam 3.6 2.4 7 6 43 21 10 23 9 22 17 15 13
Titan 5.8 3.7 14 12 87 43 12 25 13 29 14 12 15
United Spirits 5.5 4.3 9 7 51 29 12 22 13 23 1 5 16
Westlife Development 6.2 3.5 12 10 71 26 (9) 16 (9) 23 6 17 204

Paints
Akzo Nobel 4.1 3.4 7 7 34 28 16 18 16 18 1 1 5
Asian Paints 9.5 7.7 17 15 56 45 25 28 22 25 12 12 12
Berger Paints 9.9 8.3 19 17 72 60 20 22 17 19 4 4 4
Kansai Nerolac 5.9 4.7 7 6 44 35 12 14 11 14 5 10 9
Source: Bloomberg, I-Sec research

2
Consumer Staples & Discretionary, September 20, 2020 ICICI Securities
Figure 2: Stock Performance
Absolute Return (%) Relative Return (%)*
Company
1m 2m 3m 6m 12m 24m 36m 1m 2m 3m 6m 12m 24m 36m
Staples
Bajaj Consumer 4 9 25 37 (25) (58) (51) 3 3 11 6 (31) (60) (65)
Britannia (3) 0 12 54 45 25 73 (4) (5) (2) 22 39 23 60
Colgate (4) (4) 1 16 4 22 20 (5) (9) (13) (16) (2) 20 7
Dabur 2 4 16 14 11 8 65 1 (2) 2 (17) 4 6 52
Emami 9 52 85 101 18 (32) (35) 8 46 71 69 11 (34) (48)
GCPL 3 2 11 43 10 (17) 13 2 (4) (3) 11 4 (19) (0)
HUL (5) (10) 2 2 15 26 64 (6) (16) (12) (29) 9 24 51
ITC (10) (8) (4) 2 (25) (41) (33) (11) (13) (18) (30) (31) (43) (46)
Jyothy Labs 5 27 32 57 (5) (28) (28) 4 21 18 25 (12) (30) (41)
Marico (3) 2 9 42 (5) 5 9 (4) (3) (5) 10 (11) 3 (4)
Nestle (3) (7) (1) 14 25 57 121 (4) (12) (15) (18) 19 55 107
Tata Consumer (1) 28 45 105 108 130 153 (2) 22 31 73 102 128 140
Varun Beverages (10) 2 (0) 17 13 33 98 (11) (3) (14) (15) 7 31 85

Discretionary
Avenue Supermarts (5) 8 (9) 12 30 40 97 (6) 2 (23) (19) 24 38 84
Bata 6 2 2 8 (14) 33 83 5 (3) (12) (23) (20) 31 69
Jubilant Foodworks 23 34 42 60 90 70 232 22 29 28 29 84 68 218
Page Industries (2) (4) 3 3 (6) (43) (4) (3) (9) (11) (28) (12) (45) (17)
Sheela Foam 11 4 6 11 21 (8) 9 10 (1) (8) (21) 15 (10) (4)
Titan 2 17 19 29 0 41 80 1 11 5 (3) (6) 39 67
United Spirits (8) (10) (11) 5 (10) (4) 2 (9) (16) (25) (26) (16) (6) (11)
Westlife Development 5 12 31 23 42 7 70 4 7 17 (8) 36 5 57

Paints
Akzo Nobel 5 17 18 1 27 27 19 4 12 4 (31) 21 25 6
Asian Paints 8 18 27 16 31 57 62 7 13 13 (15) 25 55 48
Berger Paints 3 12 16 28 57 93 116 2 6 2 (3) 51 91 103
Kansai Nerolac 2 13 31 38 10 9 2 1 8 17 7 3 7 (11)
Source: Bloomberg, I-Sec research *Relative to Nifty 50 Index

3
4
(Rs) (Rs) (Rs) (Rs) (Rs)

320
420
520
620
720
820
920
1,020
100
200
300
400
500
600
700

100
200
300
400
500
600
700
1,300
1,500
1,900
2,100
2,500
2,700

1,700
2,300

250
300
350
400
450
500
550
600
GCPL
Sep-17 Sep-17 Sep-17 Sep-17
Sep-17
Mar-18 Mar-18 Mar-18
Mar-18 Mar-18
Akzo Nobel
Sep-18 Sep-18 Sep-18
Sep-18 Sep-18

Berger Paints
Mar-19 Mar-19 Mar-19
Mar-19 Mar-19
Price charts

Kansai Nerolac

Tata Consumer

Source: Bloomberg
Sep-19 Sep-19 Sep-19 Sep-19
Sep-19
Mar-20 Mar-20 Mar-20 Mar-20
Mar-20
Sep-20 Sep-20 Sep-20 Sep-20
Sep-20

(Rs) (Rs) (Rs) (Rs) (Rs)

200
250
300
350
400
450
HUL
600
800
1,000
1,200
1,400
1,600
2,000
2,200

1,800

Titan
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500

1100
1400
2000
2300

500
1700
2600

800

350
550
750
950
1,150
1,550
1,350
Marico
Sep-17 Sep-17 Sep-17 Sep-17
Sep-17 Britannia
Mar-18 Mar-18 Mar-18 Mar-18
Mar-18
Sep-18 Sep-18 Sep-18 Sep-18
Asian Paints

Sep-18
Mar-19 Mar-19 Mar-19 Mar-19
Mar-19
Sep-19 Sep-19 Sep-19 Sep-19
Sep-19
Mar-20 Mar-20 Mar-20 Mar-20
Mar-20
Sep-20 Sep-20 Sep-20 Sep-20
Sep-20

(Rs) (Rs) (Rs) (Rs) (Rs)

ITC

125
175
225
275
325
375
400
800
1,200
1,600
2,000
2,400
2,800

200
400
600
800
1,000
10,000
12,000
18,000
20,000

14,000
16,000

4,000
6,000
8,000
600
800
1,200
1,400
1,800

1,000
1,600

Nestle
Sep-17 Sep-17
Sep-17
Colgate

Sep-17 Sep-17
Mar-18 Mar-18 Mar-18
Mar-18 Mar-18
Sep-18
Consumer Staples & Discretionary, September 20, 2020

Sep-18 Sep-18 Sep-18 Sep-18

United Spirits
Mar-19 Mar-19 Mar-19
Mar-19 Mar-19
Sep-19 Sep-19 Sep-19 Sep-19 Sep-19
Mar-20 Mar-20 Mar-20 Mar-20 Mar-20
Avenue Supermarts

Sep-20 Sep-20 Sep-20 Sep-20 Sep-20

(Rs) (Rs) (Rs) (Rs) (Rs)

400

0
200
600
800
1,000
200
250
300
350
400
450
500
550

200
700
1,200
1,700
2,200
2,700
100
175
250
325
400
475
550

22,000
32,000
42,000

2,000
12,000
Dabur

Sep-17 Sep-17 Sep-17


Sep-17 Sep-17
Mar-18 Mar-18 Mar-18
Mar-18 Mar-18
Sep-18 Sep-18 Sep-18 Sep-18
Sep-18
Mar-19 Mar-19 Mar-19 Mar-19
Mar-19
Page Industries
Bajaj Consumer

Sep-19 Sep-19 Sep-19 Sep-19

Varun Beverages
Sep-19
Mar-20 Mar-20 Mar-20 Mar-20
Mar-20
Jubilant Foodworks

Sep-20 Sep-20 Sep-20 Sep-20


Sep-20

(Rs) (Rs) (Rs) (Rs) (Rs)


650
850
1,050
1,250
1,450
1,650
1,850
2,050
0
200
400
600
800

150

100
300
200
250
300

200
400
500
600
50
100
0
500
1,000
1,500
2,000

Sep-17 Sep-17 Sep-17 Sep-17 Sep-17


Emami

Mar-18 Mar-18 Mar-18 Mar-18 Mar-18


Bata India

Sep-18 Sep-18 Sep-18 Sep-18 Sep-18


Jyothy Labs

Sheela Foam

Mar-19 Mar-19 Mar-19 Mar-19 Mar-19


Sep-19 Sep-19 Sep-19 Sep-19 Sep-19
Mar-20 Mar-20 Mar-20 Mar-20 Mar-20
Sep-20 Sep-20 Sep-20 Sep-20
ICICI Securities

Sep-20
Westlife Development
Consumer Staples & Discretionary, September 20, 2020 ICICI Securities
In case of industry/sector reports or a report containing multiple stocks, the rating/recommendation for a particular stock may be based on the last released stock
specific report for that company.”

This report may be distributed in Singapore by ICICI Securities, Inc. (Singapore branch). Any recipients of this report in Singapore should contact ICICI Securities,
Inc. (Singapore branch) in respect of any matters arising from, or in connection with, this report. The contact details of ICICI Securities, Inc. (Singapore branch) are
as follows: Address: 10 Collyer Quay, #40-92 Ocean Financial Tower, Singapore - 049315, Tel: +65 6232 2451 and email: navneet_babbar@icicisecuritiesinc.com,
Rishi_agrawal@icicisecuritiesinc.com.

"In case of eligible investors based in Japan, charges for brokerage services on execution of transactions do not in substance constitute charge for research reports
and no charges are levied for providing research reports to such investors."

New I-Sec investment ratings (all ratings based on absolute return; All ratings and target price refers to 12-month performance horizon, unless mentioned otherwise)
BUY: >15% return; ADD: 5% to 15% return; HOLD: Negative 5% to Positive 5% return; REDUCE: Negative 5% to Negative 15% return; SELL: < negative 15% return

ANALYST CERTIFICATION
I/We, Manoj Menon, MBA, CMA; Vismaya Agarwal, CFA, BTech; Karan Bhuwania, MBA; authors and the names subscribed to this report, hereby certify that all of the
views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or
will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Analysts are not registered as research analysts by FINRA and are not
associated persons of the ICICI Securities Inc. It is also confirmed that above mentioned Analysts of this report have not received any compensation from the
companies mentioned in the report in the preceding twelve months and do not serve as an officer, director or employee of the companies mentioned in the report.
Terms & conditions and other disclosures:
ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of
financial products. ICICI Securities Limited is a SEBI registered Research Analyst with SEBI Registration Number – INH000000990. ICICI Securities Limited SEBI
Registration is INZ000183631 for stock broker. ICICI Securities is a subsidiary of ICICI Bank which is India’s largest private sector bank and has its various subsidiaries
engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. (“associates”), the details in
respect of which are available on www.icicibank.com.
ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our
associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research
Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or
derivatives of any companies that the analysts cover.
Recommendation in reports based on technical and derivative analysis centre on studying charts of a stock's price movement, outstanding positions, trading volume etc
as opposed to focusing on a company's fundamentals and, as such, may not match with the recommendation in fundamental reports. Investors may visit icicidirect.com
to view the Fundamental and Technical Research Reports.
Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein.
ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Institutional
Research. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Retail
Research.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained
herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to
any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information
herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other
reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such
suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity
to this company, or in certain other circumstances.
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy
or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or
solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers
may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes
investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities
discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment
objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The
recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange
rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is
not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the
securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change
without notice.
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject
company for any other assignment in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from
the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage
services or other advisory service in a merger or specific transaction.
ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage
services from the companies mentioned in the report in the past twelve months.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its
associates or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of
the research report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of interest at the time of publication of this
report.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
ICICI Securities or its subsidiaries collectively or Research Analysts or their relatives do not own 1% or more of the equity securities of the Company mentioned in the
report as of the last day of the month preceding the publication of the research report.
Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various
companies including the subject company/companies mentioned in this report.
ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.
We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other
jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any
registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category
of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
This report has not been prepared by ICICI Securities, Inc. However, ICICI Securities, Inc. has reviewed the report and, in so far as it includes current or historical
information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed.

You might also like